136 related articles for article (PubMed ID: 17642228)
1. [Treatment guidelines for the use of biologics in rheumatoid arthritis; present and future].
Miyasaka N; Koike R
Nihon Rinsho; 2007 Jul; 65(7):1169-78. PubMed ID: 17642228
[TBL] [Abstract][Full Text] [Related]
2. Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis.
Koike R; Takeuchi T; Eguchi K; Miyasaka N;
Mod Rheumatol; 2007; 17(6):451-8. PubMed ID: 18084695
[TBL] [Abstract][Full Text] [Related]
3. Guidelines for the proper use of etanercept in Japan.
Miyasaka N; Takeuchi T; Eguchi K
Mod Rheumatol; 2006; 16(2):63-7. PubMed ID: 16633923
[TBL] [Abstract][Full Text] [Related]
4. [Proper usage of biologics for treatment of rheumatoid arthritis].
Murayama M
Nihon Naika Gakkai Zasshi; 2009 Apr; 98(4):894-8. PubMed ID: 19469085
[No Abstract] [Full Text] [Related]
5. [Pneumonia, pneumocystis pneumonia].
Koike R; Harigai M
Nihon Rinsho; 2007 Jul; 65(7):1314-20. PubMed ID: 17642249
[TBL] [Abstract][Full Text] [Related]
6. [TNF inhibitors for treatment of rheumatoid arthritis].
Otomo K; Koike T
Nihon Naika Gakkai Zasshi; 2008 Oct; 97(10):2405-12. PubMed ID: 19149036
[No Abstract] [Full Text] [Related]
7. [Should we be afraid of the anti-TNFalpha drugs in 2008?].
Gaudin P
Rev Med Interne; 2008 Dec; 29(12):971-4. PubMed ID: 18571291
[No Abstract] [Full Text] [Related]
8. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
9. TNF blockade in the treatment of rheumatoid arthritis: infliximab versus etanercept.
Mikuls TR; Moreland LW
Expert Opin Pharmacother; 2001 Jan; 2(1):75-84. PubMed ID: 11336570
[TBL] [Abstract][Full Text] [Related]
10. [Etanercept--infliximab switch in rheumatoid arthritis 14 out of 131 patients treated with anti TNFalpha].
Brocq O; Plubel Y; Breuil V; Grisot C; Flory P; Mousnier A; Euller-Ziegler L
Presse Med; 2002 Nov; 31(39 Pt 1):1836-9. PubMed ID: 12496713
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of switching from infliximab to etanercept in patients with rheumatoid arthritis.
Laas K; Peltomaa R; Kautiainen H; Leirisalo-Repo M
Clin Rheumatol; 2008 Jul; 27(7):927-32. PubMed ID: 18414967
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of switching from etanercept to infliximab in patients with rheumatoid arthritis.
Hansen KE; Hildebrand JP; Genovese MC; Cush JJ; Patel S; Cooley DA; Cohen SB; Gangnon RE; Schiff MH
J Rheumatol; 2004 Jun; 31(6):1098-102. PubMed ID: 15170921
[TBL] [Abstract][Full Text] [Related]
13. The efficiency of switching from infliximab to etanercept and vice-versa in patients with rheumatoid arthritis.
Cohen G; Courvoisier N; Cohen JD; Zaltni S; Sany J; Combe B
Clin Exp Rheumatol; 2005; 23(6):795-800. PubMed ID: 16396697
[TBL] [Abstract][Full Text] [Related]
14. Comparison of drug retention rates and causes of drug discontinuation between anti-tumor necrosis factor agents in rheumatoid arthritis.
Du Pan SM; Dehler S; Ciurea A; Ziswiler HR; Gabay C; Finckh A;
Arthritis Rheum; 2009 May; 61(5):560-8. PubMed ID: 19405000
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor necrosis factor alpha switching in rheumatoid arthritis and juvenile chronic arthritis.
Favalli EG; Arreghini M; Arnoldi C; Panni B; Marchesoni A; Tosi S; Pontikaki I
Arthritis Rheum; 2004 Apr; 51(2):301-2. PubMed ID: 15077278
[No Abstract] [Full Text] [Related]
16. Anti-tumor necrosis factor therapies.
Taylor PC
Curr Opin Rheumatol; 2001 May; 13(3):164-9. PubMed ID: 11333343
[TBL] [Abstract][Full Text] [Related]
17. [Biological agents].
Amano K
Nihon Rinsho; 2009 Mar; 67(3):593-8. PubMed ID: 19280938
[TBL] [Abstract][Full Text] [Related]
18. [TNFalpha inhibitors for the treatment of rheumatoid arthritis].
Sany J; Kaiser MJ
Ann Med Interne (Paris); 2002 Feb; 153(1):34-40. PubMed ID: 11994688
[TBL] [Abstract][Full Text] [Related]
19. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-alpha agents.
Strangfeld A; Listing J; Herzer P; Liebhaber A; Rockwitz K; Richter C; Zink A
JAMA; 2009 Feb; 301(7):737-44. PubMed ID: 19224750
[TBL] [Abstract][Full Text] [Related]
20. Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register.
Simard JF; Neovius M; Askling J;
Arthritis Rheum; 2012 Nov; 64(11):3502-10. PubMed ID: 22886739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
